Mirae

United Kingdom · Healthtech · AI · Biotech · Enterprise software

AI-driven continuous care platform for autoimmune disease and other complex chronic conditions

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Seed$5.4MOxford Science Enterprises — Role not disclosed
Sourcesmiraehealth.com ↗